Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lumry

Showing results (81-90 of 139) with videos related to

Pageof 14
Sort By:
Allergy and Asthma Proceedings|May 17, 2025
Garadacimab improves long-term health-related quality of life in patients with hereditary angioedemaMar Guilarte, William R Lumry, Markus Magerl, et al.
Pediatrics|December 13, 2016
Management of Children With Hereditary Angioedema Due to C1 Inhibitor DeficiencyMichael M Frank, Bruce Zuraw, Aleena Banerji, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 9, 2026
Donidalorsen for hereditary angioedema: Long-term results from a 4-year phase 2 open-label extension studyMichael E Manning, Mats de Lange, Jonathan A Bernstein, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|September 5, 2006
Duplicate publicationGary D Berman, Harvey J Blumenthal, Roger K Cady, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2011
Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trialWilliam R Lumry, H Henry Li, Robyn J Levy, et al.
Allergy and Asthma Proceedings|December 10, 2016
Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedemaMarc A Riedl, William R Lumry, H Henry Li, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiencyBruce L Zuraw, Aleena Banerji, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2025
Hereditary Angioedema With Normal C1 Inhibitor: A Quarter Century of Forward Progress and Persisting ObstaclesSandra C Christiansen, Aleena Banerji, Jonathan A Bernstein, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 28, 2006
An otolaryngology, neurology, allergy, and primary care consensus on diagnosis and treatment of sinus headacheHoward L Levine, Michael Setzen, Roger K Cady, et al.
Allergy|July 21, 2021
Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE StudyAleena Banerji, Jonathan A Bernstein, Douglas T Johnston, et al.
Pageof 14

Showing results (81-90 of 139) with videos related to

Sort By:
Pageof 14
Allergy and Asthma Proceedings|May 17, 2025
Garadacimab improves long-term health-related quality of life in patients with hereditary angioedemaMar Guilarte, William R Lumry, Markus Magerl, et al.
Pediatrics|December 13, 2016
Management of Children With Hereditary Angioedema Due to C1 Inhibitor DeficiencyMichael M Frank, Bruce Zuraw, Aleena Banerji, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 9, 2026
Donidalorsen for hereditary angioedema: Long-term results from a 4-year phase 2 open-label extension studyMichael E Manning, Mats de Lange, Jonathan A Bernstein, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|September 5, 2006
Duplicate publicationGary D Berman, Harvey J Blumenthal, Roger K Cady, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2011
Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trialWilliam R Lumry, H Henry Li, Robyn J Levy, et al.
Allergy and Asthma Proceedings|December 10, 2016
Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedemaMarc A Riedl, William R Lumry, H Henry Li, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiencyBruce L Zuraw, Aleena Banerji, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2025
Hereditary Angioedema With Normal C1 Inhibitor: A Quarter Century of Forward Progress and Persisting ObstaclesSandra C Christiansen, Aleena Banerji, Jonathan A Bernstein, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 28, 2006
An otolaryngology, neurology, allergy, and primary care consensus on diagnosis and treatment of sinus headacheHoward L Levine, Michael Setzen, Roger K Cady, et al.
Allergy|July 21, 2021
Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE StudyAleena Banerji, Jonathan A Bernstein, Douglas T Johnston, et al.
Pageof 14